6cl3: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
The | ==LyeTxI-b, a synthetic peptide derived from Lycosa erythrognatha spider venom, shows potent antibiotic activity, in vitro and in vivo== | ||
<StructureSection load='6cl3' size='340' side='right'caption='[[6cl3]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6cl3]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Lycosa_erythrognatha Lycosa erythrognatha]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6CL3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6CL3 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 10 models</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6cl3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6cl3 OCA], [https://pdbe.org/6cl3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6cl3 RCSB], [https://www.ebi.ac.uk/pdbsum/6cl3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6cl3 ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/LYT1_LYCER LYT1_LYCER] | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
The antimicrobial peptide LyeTxI isolated from the venom of the spider Lycosa erythrognatha is a potential model to develop new antibiotics against bacteria and fungi. In this work, we studied a peptide derived from LyeTxI, named LyeTxI-b, and characterized its structural profile and its in vitro and in vivo antimicrobial activities. Compared to LyeTxI, LyeTxI-b has an acetylated N-terminal and a deletion of a His residue, as structural modifications. The secondary structure of LyeTxI-b is a well-defined helical segment, from the second amino acid to the amidated C-terminal, with no clear partition between hydrophobic and hydrophilic faces. Moreover, LyeTxI-b shows a potent antimicrobial activity against Gram-positive and Gram-negative planktonic bacteria, being 10-fold more active than the native peptide against Escherichia coli. LyeTxI-b was also active in an in vivo model of septic arthritis, reducing the number of bacteria load, the migration of immune cells, the level of IL-1beta cytokine and CXCL1 chemokine, as well as preventing cartilage damage. Our results show that LyeTxI-b is a potential therapeutic model for the development of new antibiotics against Gram-positive and Gram-negative bacteria. | |||
LyeTxI-b, a Synthetic Peptide Derived From Lycosa erythrognatha Spider Venom, Shows Potent Antibiotic Activity in Vitro and in Vivo.,Reis PVM, Boff D, Verly RM, Melo-Braga MN, Cortes ME, Santos DM, Pimenta AMC, Amaral FA, Resende JM, de Lima ME Front Microbiol. 2018 Apr 6;9:667. doi: 10.3389/fmicb.2018.00667. eCollection, 2018. PMID:29681894<ref>PMID:29681894</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: | <div class="pdbe-citations 6cl3" style="background-color:#fffaf0;"></div> | ||
[[Category: Resende | == References == | ||
[[Category: Verly | <references/> | ||
[[Category: De Lima | __TOC__ | ||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Lycosa erythrognatha]] | |||
[[Category: Resende JM]] | |||
[[Category: Verly RM]] | |||
[[Category: De Lima ME]] | |||
[[Category: Dos Reis PV]] | |||
Latest revision as of 09:47, 23 October 2024
LyeTxI-b, a synthetic peptide derived from Lycosa erythrognatha spider venom, shows potent antibiotic activity, in vitro and in vivo
| ||||||||||||
